Key facts
- Pangaea (Enterprise Systems)’s last known valuation is $37.4M (May 2025).
- It has raised $6.9M; the latest was Later Stage VC ($2.7M) in May 2025.
- Notable investors include Microsoft for Startups, FinTech Innovation Lab, Salica Investments, Ascension, Meltwind Advisory — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Pangaea (Enterprise Systems)
- ·The full record, as it builds
Funding rounds
No funding rounds for Pangaea (Enterprise Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pangaea (Enterprise Systems)
Developer of an EHR data analysis platform designed to help carry out clinical trials and studies for drugs. The company's software uses machine learning to find symptomatic patients based on specific phenotypes and helps to recruit them for drug testing, enabling researchers and testers to examine new treatments on desired candidates easily.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2017
- Employees
- 28
- Website
- pangaeadata.ai/
- Ownership
- Privately Held (backing)
Pangaea (Enterprise Systems) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pangaea (Enterprise Systems) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pangaea (Enterprise Systems) in its N-PORT filings yet. We sweep new filings monthly.